Literature DB >> 34091664

Early Monoclonal Antibody Administration Can Reduce Both Hospitalizations and Mortality in High-Risk Outpatients With Coronavirus Disease 2019 (COVID-19).

Jeffrey D Jenks1, Saima Aslam1, Lucy E Horton1, Nancy Law1, Ajay Bharti1, Cathy Logan1, Mahnaz Taremi1, Florin Vaida2, Michele Ritter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 34091664      PMCID： PMC8195212          DOI： 10.1093/cid/ciab522

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  9 in total

1.  Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.

Authors:  Saima Aslam; Jinyuan Liu; Rachel Sigler; Rehan R Syed; Xin M Tu; Susan J Little; Victor De Gruttola
Journal:  Transpl Infect Dis       Date:  2022-02-24

Review 2.  COVID-19 in the Immunocompromised Host, Including People with Human Immunodeficiency Virus.

Authors:  Niyati Jakharia; Aruna K Subramanian; Adrienne E Shapiro
Journal:  Infect Dis Clin North Am       Date:  2022-02-01       Impact factor: 5.905

3.  A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy.

Authors:  Mei H Chang; Kelsie Cowman; Yi Guo; Hongkai Bao; Peter S Bernstein; Inessa Gendlina; Priya Nori
Journal:  Am J Obstet Gynecol       Date:  2022-01-21       Impact factor: 10.693

4.  Bamlanivimab Efficacy in Older and High-BMI Outpatients With COVID-19 Selected for Treatment in a Lottery-Based Allocation Process.

Authors:  Emily B Rubin; Jonathan A Boiarsky; Lauren A Canha; Anita Giobbie-Hurder; Mofei Liu; Matthew J Townsend; Michael Dougan
Journal:  Open Forum Infect Dis       Date:  2021-11-03       Impact factor: 3.835

5.  Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review.

Authors:  David Klank; Martin Hoffmann; Bernd Claus; Florian Zinke; Raoul Bergner; Peter Paschka
Journal:  Hemasphere       Date:  2021-10-27

6.  Use of anti-spike monoclonal antibodies in kidney transplant recipients with COVID-19: Efficacy, ethnic and racial disparities.

Authors:  Elizabeth J Klein; Anna Hardesty; Kendra Vieira; Dimitrios Farmakiotis
Journal:  Am J Transplant       Date:  2021-09-30       Impact factor: 9.369

7.  Real-world Assessment of 2879 COVID-19 Patients Treated With Monoclonal Antibody Therapy: A Propensity Score-Matched Cohort Study.

Authors:  Megan H Cooper; Paul A Christensen; Eric Salazar; Katherine K Perez; Edward A Graviss; Duc Nguyen; James M Musser; Howard J Huang; Michael G Liebl
Journal:  Open Forum Infect Dis       Date:  2021-10-08       Impact factor: 4.423

8.  Assessment of unvaccinated and vaccinated patients with coronavirus disease 2019 (COVID-19) treated with monoclonal antibodies during the delta wave (July 1-August 20, 2021): a retrospective observational monocentric study.

Authors:  Yi Guo; Kelsie Cowman; Mei Chang; Hongkai Bao; Austin Golia; Terrence Mcsweeney; Linda Bard; Roxanne Simpson; Erin Andrews; Liise-Anne Pirofski; Priya Nori
Journal:  BMC Infect Dis       Date:  2022-07-27       Impact factor: 3.667

9.  Low mortality in SARS-CoV-2 infected heart transplant recipients at a single center.

Authors:  Jason M Duran; Masihullah Barat; Andrew Y Lin; Kevin R King; Barry Greenberg; Eric D Adler; Saima Aslam
Journal:  Clin Transplant       Date:  2021-12-13       Impact factor: 3.456
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.